Want to see HTFL full AI Analyst Report?
HTFL Stock Chart & Stats
$31.34
--
Market closed
$31.34
--
Day’s Range― - ―
52-Week Range$20.13 - $41.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.82M
Market Cap
$2.34B
Enterprise Value$2.84B
Total Cash (Recent Filing)$158.32M
Total Debt (Recent Filing)$26.35M
Price to Earnings (P/E)―
Beta1.98
Next Earnings
Aug 06, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.86
Shares Outstanding86,240,830
10 Day Avg. Volume3,070,118
30 Day Avg. Volume1,824,252
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)35.73
Price to Sales (P/S)61.03
P/FCF Ratio-181.94
Enterprise Value/Market Cap1.21
Enterprise Value/Revenue14.83
Enterprise Value/Gross Profit19.00
Enterprise Value/Ebitda-30.56
Forecast
1Y Price Target
$37.33Price Target Upside19.12% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)-0.49
Revenue Forecast (FY)$229.93M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent, accelerating top-line growth demonstrates durable demand for HeartFlow's FFRCT diagnostic service and expanding clinical adoption. A rising revenue base supports scale benefits, strengthens payer/provider engagement, and underpins longer-term margin and operating leverage prospects as per-test volume grows.
High And Improving Gross MarginsElevated, rising gross margins indicate attractive unit economics for software-driven FFRCT analyses. Strong per-test margins signal that incremental revenue predominantly flows to the operating line, enabling the company to convert scale into sustainable operating profit if fixed costs are controlled and volume continues to grow.
Lower Leverage, Balance Sheet ImprovementMarked reduction in debt and a low 2025 debt-to-equity ratio, plus equity turning positive, materially reduce short-term financing risk. A healthier balance sheet increases strategic optionality for commercial investments and lessens refinancing pressure while the business works toward operating profitability.
Bears Say
Persistent Operating LossesDespite top-line and margin progress, large and ongoing operating and net losses mean the company is not yet self-sustaining. Continued negative profitability pressures cash needs, limits reinvestment from internal funds, and raises execution risk until fixed costs are absorbed or revenue sufficiently scales.
Ongoing Cash BurnMaterial negative operating and free cash flow require external financing until the business generates sustainable positive cash. Persistent cash burn increases dilution or refinancing risk, constrains investment flexibility, and means management must balance growth initiatives against the need to conserve cash.
Volatile Balance Sheet HistoryPrior periods of negative equity reflect accumulated losses or recapitalization, which can signal past dilution and governance/financing stress. Even with 2025 improvements, this history increases the risk of future capital raises and weakens confidence in sustained capital structure stability until consistent profitability is achieved.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $20.13 and its highest was $41.22 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
HeartFlow, Inc.’s market cap is $2.34B.
When is HeartFlow, Inc.’s upcoming earnings report date?
HeartFlow, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 29 days.
How were HeartFlow, Inc.’s earnings last quarter?
HeartFlow, Inc. released its earnings results on May 14, 2026. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.188 by $0.028.
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate is -0.13.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 86,240,830 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
HeartFlow, Inc. reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.188. Following the earnings report the stock price went down -12.174%.
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HeartFlow, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.33 (19.12% Upside)
$37.33 (19.12% Upside)
Blogger Sentiment
Neutral
HTFL Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $58.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
Fundamentals
Return on Equity
830.46%
Trailing 12-Months
Asset Growth
86.52%
Trailing 12-Months
Company Description
HeartFlow, Inc.
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
HTFL Earnings Call
Q1 2026
0:00 / 0:00
HTFL Stock 12 Month Forecast
Average Price Target
$37.33
▲(19.12% Upside)
Technical Analysis
Ownership Overview
17.74% Insiders
27.21% Mutual Funds
0.05% Other Institutional Investors
45.86% Public Companies and
Individual Investors